SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869) (CAPR) — May 23, 2006

CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)
Date: May 23, 2006 · CIK: 0001133869 · Accession: 0001092306-06-000380

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-55166

Referenced dates: April 18, 2006

Date
May 16, 2006
Author
President and Director
Form
CORRESP
Company
CAPRICOR THERAPEUTICS, INC. (CAPR) (CIK 0001133869)

Letter

RE: SMI Products, Inc. ("Registrant") Form 10-KSB/A Filed April 4, 2006 File Number 333-55166

SMI PRODUCTS, INC. 3503 Cedar Locust Sugarland, TX 77479

May 16, 2006

MAIL STOP 3561

Tia Jenkins Senior Assistant Chief Accountant U.S. Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549

Ladies/Gentlemen:

In response to your comments dated April 18, 2006, the Registrant has made the following amendments, corresponding to your enumerated paragraphs:

ITEM 8A. CONTROLS AND PROCEDURES

1. The document has been amended to include the information required by Items 307 and 308(c) of Regulation S-B.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

2. The document has been amended to include the information required by Item 9(e) of Schedule 14A.

In addition, the Registrant hereby acknowledges that:

1. the Registrant is responsible for the adequacy and accuracy of the disclosure in the filing;

2. staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and

3. the Registrant may not asset staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

If you have any further questions or comments regarding this filing, please do not hesitate to contact me.

Very truly yours,
/s/ JAMES M. CHARUK
__________________________
James M. Charuk
President and Director

Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>

                               SMI PRODUCTS, INC.
                                3503 Cedar Locust
                               Sugarland, TX 77479

May 16, 2006

MAIL STOP 3561

Tia Jenkins
Senior Assistant Chief Accountant
U.S. Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C. 20549

RE:   SMI Products, Inc. ("Registrant")
      Form 10-KSB/A
      Filed April 4, 2006
      File Number 333-55166

Ladies/Gentlemen:

In response to your comments  dated April 18, 2006,  the Registrant has made the
following amendments, corresponding to your enumerated paragraphs:

ITEM 8A. CONTROLS AND PROCEDURES

1.   The document has been amended to include the information  required by Items
     307 and 308(c) of Regulation S-B.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

2.   The document has been amended to include the  information  required by Item
     9(e) of Schedule 14A.

In addition, the Registrant hereby acknowledges that:

     1.   the  Registrant  is  responsible  for the adequacy and accuracy of the
          disclosure in the filing;

     2.   staff  comments or changes to disclosure in response to staff comments
          do not foreclose the Commission from taking any action with respect to
          the filing; and

     3.   the  Registrant  may not asset  staff  comments  as a  defense  in any
          proceeding initiated by the Commission or any person under the federal
          securities laws of the United States.

If you have any further questions or comments  regarding this filing,  please do
not hesitate to contact me.

Very truly yours,

/s/ JAMES M. CHARUK
__________________________
    James M. Charuk
    President and Director

cc: Amisano Hanson, Chartered Accountants
    Michael J. Morrison, Esq.

</TEXT>
</DOCUMENT>